| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.3% | $32,960,388 | 6,070,053 | BlackRock, Inc. | 31 Dec 2024 | |||
| Deep Track Capital, LP | 6.9% | -16% | $64,845,000 | -$11,790,000 | 5,500,000 | -15% | Deep Track Capital, LP | 30 Sep 2025 |
As of 30 Sep 2025, 192 institutional investors reported holding 39,739,020 shares of Mind Medicine (MindMed) Inc. - Common Shares (MNMD). This represents 50% of the company’s total 80,058,224 outstanding shares.
The largest institutional shareholders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.4% | 5,935,557 | +2.3% | 0% | $69,980,216 |
| Commodore Capital LP | 4% | 3,225,000 | -36% | 1.9% | $38,022,750 |
| Driehaus Capital Management LLC | 3.9% | 3,109,911 | +0.56% | 0.26% | $36,665,851 |
| Blackstone Inc. | 3.5% | 2,776,561 | -23% | 0.14% | $32,735,654 |
| MARSHALL WACE, LLP | 3% | 2,381,980 | -30% | 0.03% | $28,083,543 |
| Octagon Capital Advisors LP | 2.7% | 2,130,000 | 0% | 3.9% | $25,112,700 |
| VANGUARD GROUP INC | 2.5% | 2,012,874 | +11% | 0% | $23,731,784 |
| STATE STREET CORP | 2.4% | 1,924,893 | +6.6% | 0% | $22,694,488 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,824,701 | +5.3% | 0% | $21,516,698 |
| Deep Track Capital, LP | 1.9% | 1,500,000 | -40% | 0.49% | $17,685,000 |
| AWM Investment Company, Inc. | 1.5% | 1,215,662 | 0% | 1.3% | $14,332,655 |
| Rosalind Advisors, Inc. | 0.94% | 750,000 | +79% | 3.2% | $8,842,500 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.79% | 633,702 | +5.9% | 0% | $7,471,347 |
| NORTHERN TRUST CORP | 0.79% | 628,538 | +4.9% | 0% | $7,410,463 |
| TANG CAPITAL MANAGEMENT LLC | 0.75% | 600,200 | 0% | 0.27% | $7,076,358 |
| UBS Group AG | 0.69% | 551,809 | +7.3% | 0% | $6,505,829 |
| GOLDMAN SACHS GROUP INC | 0.69% | 550,630 | +435% | 0% | $6,491,928 |
| MORGAN STANLEY | 0.62% | 495,618 | -28% | 0% | $5,843,338 |
| ORBIMED ADVISORS LLC | 0.46% | 367,824 | 0.1% | $4,336,645 | |
| Ally Bridge Group (NY) LLC | 0.45% | 361,444 | -50% | 3.6% | $4,261,425 |
| CITADEL ADVISORS LLC | 0.42% | 339,438 | +90% | 0% | $4,001,974 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.37% | 300,000 | 0.01% | $3,537,000 | |
| MILLENNIUM MANAGEMENT LLC | 0.37% | 298,205 | +63% | 0% | $3,515,837 |
| TWO SIGMA INVESTMENTS, LP | 0.37% | 296,443 | +425% | 0.01% | $3,495,063 |
| JANE STREET GROUP, LLC | 0.34% | 274,848 | +114% | 0% | $3,240,458 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 81,785 | $1,096,747 | -$72,581 | $13.39 | 9 |
| 2025 Q3 | 39,739,020 | $468,541,734 | -$19,315,518 | $11.79 | 192 |
| 2025 Q2 | 41,774,953 | $270,842,372 | +$4,339,704 | $6.49 | 176 |
| 2025 Q1 | 41,095,554 | $240,392,790 | -$3,662,056 | $5.85 | 185 |
| 2024 Q4 | 41,492,753 | $288,778,973 | -$56,726,946 | $6.96 | 168 |
| 2024 Q3 | 49,467,087 | $281,475,077 | +$41,687,937 | $5.69 | 155 |
| 2024 Q2 | 41,519,449 | $299,342,330 | +$37,966,066 | $7.21 | 148 |
| 2024 Q1 | 34,806,070 | $327,170,962 | +$282,648,979 | $9.40 | 126 |
| 2023 Q4 | 36,826 | $134,783 | +$10,343 | $3.66 | 1 |
| 2023 Q3 | 3,862,170 | $12,088,684 | -$416,564 | $3.13 | 85 |
| 2023 Q2 | 3,867,050 | $13,804,517 | -$152,452 | $3.57 | 73 |
| 2023 Q1 | 3,946,071 | $12,509,481 | -$1,828,151 | $3.17 | 75 |
| 2022 Q4 | 4,949,447 | $10,887,594 | +$2,053,364 | $2.20 | 80 |
| 2022 Q3 | 3,713,435 | $12,991,457 | +$12,335,442 | $3.50 | 51 |
| 2022 Q1 | 0 | $0 | -$18,000 | $13.39 | 0 |
| 2021 Q4 | 13,006 | $18,000 | $0 | $1.38 | 1 |